Nephrostomy Devices Market – By Product, By Application, By Patient Type, By End Use, Global Forecast, 2025 to 2034

Nephrostomy Devices Market Size

The global nephrostomy devices market size was valued at USD 1.3 billion in 2024 and is expected to exhibit growth at a CAGR of 8.5% from 2025 to 2034. The market growth is attributed to the rising prevalence of kidney-related disorders such as kidney stones, hydronephrosis, and urinary tract infections. Also, increasing adoption of minimally invasive procedures and advancements in nephrostomy technologies are further fueling market expansion.
 

Kidney stones alone affect approximately 10% of men and 7% of women worldwide, with recurrence rates as high as 50% within 10 years. Conditions like hydronephrosis, which results from urinary tract blockages, often necessitate nephrostomy to relieve pressure on the kidneys and prevent long-term damage.
 

Furthermore, innovations in device design, such as flexible guidewires with hydrophilic coatings and balloon catheters with enhanced inflation control, have enhanced procedural efficiency and patient safety. These advancements not only reduce procedural complications but also improve patient comfort during and after the procedure. The growing preference for minimally invasive techniques is evident in regions with advanced healthcare systems, such as North America and Europe, where outpatient nephrostomy procedures are becoming increasingly common.  
 

Nephrostomy devices are medical instruments used to drain urine from the kidneys when the normal flow of urine is obstructed due to conditions like kidney stones, tumors, or bladder obstructions. These devices typically consist of a catheter inserted through the skin into the renal pelvis to bypass the urinary tract blockage and allow for the safe drainage of urine. Nephrostomy devices are commonly used in cases of hydronephrosis or when a percutaneous nephrostomy procedure is required.
 

Nephrostomy Devices Market Trends

The market is witnessing transformative trends that are shaping its growth trajectory. A major trend is the growing preference for minimally invasive nephrostomy procedures, which improve patient outcomes and reduce hospitalization periods. Additionally, manufacturers are investing in the development of innovative materials, such as biocompatible polymers, which enhance patient comfort and reduce the risk of infections.
 

• Another trend is the integration of smart technologies, such as imaging-guided insertion systems and advanced drainage tubes. These innovations allow for precise device placement and improved procedural success rates, boosting market adoption. Furthermore, the increasing focus on pediatric nephrostomy devices to cater to specialized needs is creating a niche segment within the broader market.
   
• Geographically, emerging economies like China and India are witnessing rapid adoption due to expanding healthcare infrastructure and rising healthcare spending. In developed regions such as North America and Europe, the adoption of value-based healthcare systems is promoting the use of cost-effective nephrostomy solutions, ensuring market expansion.
   

Nephrostomy Devices Market Analysis

Based on product, the market is segmented as guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and other products. The guidewires segment generated revenue of USD 415.2 million in 2024.
 

• Guidewires dominate the market due to their pivotal role in facilitating safe and accurate catheter placement. Their flexibility, ease of navigation, and compatibility with various nephrostomy catheters make them indispensable during procedures. Recent advancements, such as hydrophilic coatings, have enhanced their maneuverability, reducing procedural complications.
   
• Additionally, the increasing focus on precision and patient safety has led to the development of specialized guidewires for pediatric and geriatric patients. Their high demand across hospitals and ambulatory surgical centers is attributed to their versatility in treating diverse urological conditions, including kidney stones and urinary obstructions.
   

Based on application, the market is segmented as kidney stones, urinary tract infections, bladder cancer, and other applications. The kidney stones segment is expected to drive business growth and expand at a CAGR of 9.1%, reaching over USD 1.1 billion by 2034.
 

• The kidney stones segment accounts for a significant share of the nephrostomy devices market, driven by the rising prevalence of nephrolithiasis globally. Kidney stones often cause severe urinary blockages, necessitating nephrostomy procedures for effective drainage. The increasing incidence of sedentary lifestyles, poor dietary habits, and dehydration are further contributing to the growing burden of kidney stones, thereby fueling product demand.
   
• In addition, advancements in imaging techniques and minimally invasive procedures have increased the success rates of nephrostomy for kidney stone management. Hospitals and clinics rely heavily on these devices for efficient treatment, ensuring their dominance in the application segment.
   

Based on patient type, the market is segmented as adult and pediatric. The adult segment is expected to drive business growth and expand at a CAGR of 8.8%, reaching over USD 2.4 billion by 2034.
 

• The adult segment leads the nephrostomy devices market, primarily due to the higher prevalence of kidney-related disorders among the adult population. Adults are more prone to developing conditions such as kidney stones and bladder cancer due to lifestyle factors, occupational hazards, and comorbidities. This demographic requires regular nephrostomy interventions, driving market demand.
   
• Moreover, increasing awareness about urological health and the availability of advanced treatment options have encouraged adults to seek early medical intervention. This trend, combined with improved healthcare access, particularly in developed regions, further supports the dominance of the adult segment.
   

Based on end use, the market is segmented as hospitals, clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 48.1% in 2024.
 

• Hospitals dominate the end-use segment of the nephrostomy devices market, owing to their ability to handle complex procedures and provide specialized care. Hospitals are equipped with advanced imaging technologies and skilled professionals, ensuring the success of nephrostomy procedures. Their capacity to manage high patient volumes further reinforces their position as key end-users.
   
• Additionally, the availability of reimbursement policies for hospital-based nephrostomy treatments in many regions has bolstered the adoption of these devices. The preference for hospital settings for critical urological interventions ensures their continued dominance in the market.
   

U.S. nephrostomy devices market accounted for USD 480.2 million in 2024 and is anticipated to grow at a CAGR of 7.8% between 2025 to 2034.
 

• The U.S. dominates the global market, driven by a high burden of kidney stones and related conditions. According to the CDC, approximately 15% of the U.S. adults suffer from chronic kidney disease, necessitating effective treatment solutions such as nephrostomy devices. The presence of key market players and high healthcare expenditure further strengthens the market.
   
• Moreover, the availability of advanced imaging technologies in hospitals and clinics ensures precision and success in nephrostomy procedures. Government initiatives like Medicare reimbursement policies for minimally invasive procedures also support the market's growth, making the U.S. a key revenue contributor globally.
   

UK nephrostomy devices market is projected to grow remarkably in the coming years.
 

• The market in the UK is growing due to the rising incidence of urinary obstructions caused by kidney stones and bladder cancer. The National Health Service (NHS) ensures wide accessibility to nephrostomy procedures, making treatment affordable and efficient. Advanced minimally invasive technologies have gained traction, reducing recovery times and increasing procedural success rates.
   
• Additionally, awareness programs run by healthcare organizations, such as Kidney Care UK, emphasize the importance of early diagnosis. This proactive approach, combined with the growing geriatric population, has led to a significant increase in the adoption of nephrostomy devices in the UK.
   

China holds a dominant position in the Asia Pacific nephrostomy devices market.
 

• China's market for nephrostomy devices is expanding rapidly due to the rising prevalence of kidney stones and hydronephrosis, driven by unhealthy diets and inadequate hydration habits. Government investments in healthcare infrastructure and access to advanced medical technologies have further propelled the market. The adoption of nephrostomy devices is also supported by growing awareness of urological health in urban areas.
   
• Local manufacturers are introducing cost-effective devices, increasing adoption rates in hospitals and clinics. Additionally, healthcare reforms and the expansion of insurance coverage for minimally invasive procedures have enhanced the accessibility of nephrostomy treatments across the country.
   

Nephrostomy Devices Market Share

Key players in the market are driving innovation to maintain a competitive edge. Companies like Boston Scientific and B. Braun have introduced advanced guidewires and catheters with hydrophilic coatings for enhanced procedural success. Additionally, strategic partnerships, such as Cook Medical’s collaboration with hospitals to provide customized nephrostomy kits, are reshaping the market landscape. Emerging players are focusing on cost-effective solutions for developing markets. Regulatory approvals, such as FDA clearances for new devices, further stimulate competition. These developments collectively enhance the efficiency and accessibility of nephrostomy devices, catering to the growing demand across both developed and emerging regions.
 

Nephrostomy Devices Market Companies

Prominent players operating in the nephrostomy devices industry include:

• angiodynamics
• B. Braun
• BD
• Boston Scientific
• CardinalHealth
• Coloplast
• Cook
• Envaste
• meditech
• NeoMedical
• OLYMPUS
• rocamed
• Teleflex
• Uresil   
   

Nephrostomy Devices Industry News:

• In March 2024, Calyxo, Inc. received FDA approval for its redesigned CVAC System. This innovative device integrates ureteroscopy, laser lithotripsy, irrigation, and aspiration, enabling a minimally invasive approach to kidney stone removal.
   

The nephrostomy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Guidewires
• Drainage tubes
• Nephrostomy catheters
• Sheath dilators
• Other products

Market, By Application

• Kidney stones
• Urinary tract infections
• Bladder cancer
• Other applications

Market, By Patient Type

• Adult
• Pediatric

Market, By End Use

• Hospitals
• Clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE